Organon Analyst Ratings
Organon Analyst Ratings
Organon Analyst Ratings
Piper Sandler Reaffirms Their Buy Rating on Organon (OGN)
Morgan Stanley Lifts Price Target on Organon to $18 From $17, Keeps Equalweight Rating
Teva Upgraded at J.P. Morgan on Upcoming Catalysts
Organon Analyst Ratings
Piper Sandler Remains a Buy on Organon (OGN)
Piper Sandler Maintains Overweight on Organon, Lowers Price Target to $22
Organon Analyst Ratings
Analyst Ratings for Organon
Goldman Sachs Downgrades Organon to Neutral, Lowers Price Target to $16
Organon Analyst Ratings
Piper Sandler Maintains Overweight on Organon, Lowers Price Target to $32
Organon Analyst Ratings
Morgan Stanley Maintains Equal-Weight on Organon, Lowers Price Target to $22
Organon Analyst Ratings
Organon Analyst Ratings
Organon Analyst Ratings
Morgan Stanley Cuts Price Target on Organon to $25 From $26, Maintains Equal-Weight Rating